1. Kim Z, Min SY, Yoon CS, et al. The basic facts of Korean breast cancer in 2011: results of a nationwide survey and breast cancer registry database. J Breast Cancer. 17:99–106. 2014.
Article
2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 347:1233–1241. 2002.
Article
3. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet. 17:2087–2106. 2005.
4. Rapiti E, Fiorreta G, Vlastos G, et al. Breast-conserving surgery has equivalent effect as mastectomy on stage I breast cancer prognosis only when followed by radiotherapy. Radiother Oncol. 69:277–284. 2003.
Article
5. Buchholz TA, Gurqoze E, Bice WS, et al. Dosimetric analysis of intact breast irradiation in off-axis planes. Int J Radiat Oncol Biol Phys. 39:261–267. 1997.
Article
6. Solin LJ, Chu JC, Sontag MR, et al. Three-dimensional photon treatment planning of the intact breast. Int J Radiat Oncol Biol Phys. 21:193–203. 1991.
Article
7. Sun LM, Meng FY, Yang TH, et al. Field-in-field plan does not improve dosimetric outcome compared with the wedged beams plan for breast cancer radiotherapy. Med Dosim. 39:79–82. 2014.
8. Sasaoka M, Futami T. Dosimetric evaluation of whole breast radiotherapy using field-in-field technique in early-stage breast cancer. Int J Clin Oncol. 16:250–256. 2011.
Article
9. Onal C, Sonmez A, Arslan G. Dosimetric comparison of the field-in-field technique and tangential wedged beams for breast irradiation. Jpn J Radiol. 30:218–226. 2012.
Article
10. Barnett GC, Wilkinson J, Moody AM, et al. A randomized controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: Baseline characteristics and dosimetry results. Radiother Oncol. 92:34–41. 2009.
11. Mukesh MB, Barnett GC, Wilkinson JS, et al. Randomized controlled trial of intensitymodulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis. J Clin Oncol 31;4488–4495 (. 2013.
12. Marks LB, Yu X, Vujaskovic Z, et al. Radiation-induced lung injury. Semin Radiat Oncol. 13:333–345. 2003.
Article
13. Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 45:323–329. 1999.
Article
14. Claude L, Perol D, Ginestet C, et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small cell lung cancer. Radiother Oncol. 71:175–181. 2004.
15. Zhang XJ, Sun JG, Sun J, et al. Prediction of radiation pneumonitis in lung cancer patients: a systemic review. J Cancer Res Clin Oncol. 138:2103–2116. 2012.
16. Blom Goldman U, Anderson M, Wennberg B, et al. Radiation pneumonitis and pulmonary function with lung dosevolume constraints in breast cancer irradiation. J Radiother Pract. 13:211–217. 2014.
Article
17. Harris EE, Correa C, Hwang WT, et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast conservation treatment. J Clin Oncol. 24:4100–4106. 2006.
18. Borger JH, Hooning MJ, Boersma LJ, et al. Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: the role of irradiated heart volume. Int J Radiat Oncol Biol Phys. 69:1131–1138. 2007.
Article
19. Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 368:987–998. 2013.
Article